WIF1 and non-small cell lung carcinoma: Therefore, inhibition of miR-181c enhanced cisplatin sensitivity in DDP-resistant NSCLC cells and also repressed the Wnt/β-catenin signaling cascade by targeting WIF1 (Zhang H. et al., 2017b).